Cargando…
A Comparison of PET Tracers in Recurrent High-Grade Gliomas: A Systematic Review
Humans with high-grade gliomas have a poor prognosis, with a mean survival time of just 12–18 months for patients who undergo standard-of-care tumor resection and adjuvant therapy. Currently, surgery and chemoradiotherapy serve as standard treatments for this condition, yet these can be complicated...
Autores principales: | Muthukumar, Sankar, Darden, Jordan, Crowley, James, Witcher, Mark, Kiser, Jackson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820099/ https://www.ncbi.nlm.nih.gov/pubmed/36613852 http://dx.doi.org/10.3390/ijms24010408 |
Ejemplares similares
-
The Clinical Value of PET with Amino Acid Tracers for Gliomas WHO Grade II
por: Smits, Anja, et al.
Publicado: (2011) -
Identify glioma recurrence and treatment effects with triple-tracer PET/CT
por: Li, Cong, et al.
Publicado: (2021) -
Amino acid tracers in PET imaging of diffuse low-grade gliomas: a systematic review of preoperative applications
por: Näslund, Olivia, et al.
Publicado: (2018) -
Feasibility and robustness of dynamic (18)F-FET PET based tracer kinetic models applied to patients with recurrent high-grade glioma prior to carbon ion irradiation
por: Debus, Charlotte, et al.
Publicado: (2018) -
Prostate-Specific Membrane Antigen as Target for Neuroimaging of Central Nervous System Tumors
por: Stopa, Brittany M., et al.
Publicado: (2022)